查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1882989

生物可吸收冠状动脉支架市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察与预测（2024-2032）

Bioresorbable Coronary Stents Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 165 Pages | 商品交期: 请询问到货日

价格

生物可吸收冠状动脉支架市场成长驱动因子

随着全球对先进心血管治疗需求的不断增长，全球生物可吸收冠状动脉支架市场持续稳定扩张。根据最新市场数据，预计2024年全球市场规模将达到3.405亿美元，2025年将成长至3.56亿美元，到2032年将进一步成长至5.204亿美元，预测期内复合年增长率（CAGR）为5.6%。北美地区凭藉其强大的医疗基础设施和较高的冠状动脉介入治疗数量，在2024年将引领全球市场，占全球市场占有率的38.59%。

生物可吸收冠状动脉支架（也称为支架）旨在疏通阻塞的动脉后逐渐溶解，从而避免与永久性金属植入物相关的长期併发症。这些装置主要由先进聚合物或可生物降解金属製成，可在体内安全降解前提供暂时的机械支撑。它们能够恢復血管的自然舒缩功能并降低晚期支架血栓形成的风险，这极大地促进了其广泛应用。

市场推动因素

市场成长的关键推动因素是冠状动脉疾病 (CAD) 在全球日益普遍。生活方式相关因素，例如饮酒量增加、吸烟、缺乏运动和慢性压力，都导致了心臟病发病率的急剧上升。例如，美国疾病管制与预防中心 (CDC) 在 2024 年 10 月报告称，到 2023 年，大约每 20 名 20 岁及以上的美国成年人中就有 1 人患有冠状动脉疾病 (CAD)，这凸显了有效治疗的紧迫性。随着全球人口老化，需要微创心臟治疗的患者人数持续成长。生物可吸收支架具有多项临床优势，包括减少长期併发症和恢復血管功能，因此在已开发国家和发展中国家的医疗保健市场需求不断增长。

市场限制因子

儘管生物可吸收冠状动脉支架具有诸多优势，但它们面临着来自药物洗脱支架 (DES) 和金属支架的激烈竞争，后者拥有成熟的临床记录、成本效益和大量的临床数据。虽然生物可吸收支架的初步结果令人鼓舞，但仍需要更长期的证据来验证其安全性和有效性。此外，再狭窄和长期血管癒合方面的不确定性仍然是临床医生关注的问题，这可能会阻碍其广泛应用。

市场机会

在医疗基础设施不断改善和公众对心臟病的认识不断提高的推动下，发展中地区正在涌现出巨大的成长机会。政府主导的举措，例如印度卫生部于2023年9月启动的“心臟健康运动”，正在帮助患者了解包括先进支架在内的各种治疗方案。世界各地的医院也正在扩展其心臟病服务。例如，澳洲坎培拉医院于2024年8月启用了一座新的重症监护服务大楼，扩大了其介入性心臟病学能力。预计这将推动对生物可吸收支架的需求。

市场挑战

生物可吸收冠状动脉支架成本高昂是市场面临的主要挑战之一，这是由于其采用了先进的生物材料和复杂的製造过程。截至2025年6月，印度BVS治疗的费用在2,500美元至5,000美元之间，这限制了中低收入国家的可及性。此外，企业必须在临床试验和监管合规方面投入巨资，从而延缓了产品的上市和推广。

主要市场趋势

创新仍是市场成长的核心。製造商正在投资新材料技术、增强药物洗脱能力和改进支架设计。新一代镁支架的出现，例如BIOTRONIK公司的Freesolve（已在2024年5月进行的BIOMAG-II试验中进行了评估），代表着一项重大进步。混合支架设计和生物感测器整合支架正成为未来的解决方案，可提供即时监测和个人化治疗。

区域洞察

北美

2024年，北美市场以1.314亿美元的规模领先全球市场。冠状动脉疾病的高发病率和微创手术的日益普及推动了该地区的需求。

欧洲

欧洲占第二大市场占有率，这得益于不断上升的肥胖率和强劲的产品上市。光是在英格兰，2021年至2022年间，就有25.6%的成年人被报告为肥胖。

亚太地区

2024年，亚太地区排名第三。高吸烟率、压力大的生活方式和支架植入量的增加是背后的原因。支架治疗病例占比从2019年的13.8%增加到2021年的19.4%。

拉丁美洲、中东和非洲

由于高血压、糖尿病和生活型态相关疾病的风险因素不断增加，这些地区的市场规模持续扩大。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场推动因素
  • 市场阻碍因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 主要国家和地区主要疾病发生率（2023/2024）
  • 主要产业趋势（併购、合作等）
  • 生物可吸收冠状动脉支架的技术进步
  • 新产品发布
  • 主要疾病的报销方案流程

第五章：全球生物可吸收冠状动脉支架市场分析、洞察与预测（2019-2032）

  • 市场分析、洞察与预测 - 依材料分类
    • 金属
    • 聚合物
  • 市场分析、洞察与预测 - 依应用分类
    • 急性冠状动脉症候群 (ACS)
    • 慢性冠状动脉症候群 (CCS)
  • 市场分析、洞察与预测 - 依最终用户分类
    • 医院和门诊手术中心 (ASC)
    • 专科诊所
    • 其他
  • 市场分析、洞察与预测 - 依地区分类
    • 北美美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美生物可吸收冠状动脉支架市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲生物可吸收冠状动脉支架市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚半岛
    • 欧洲其他地区

第八章亚太地区生物可吸收冠状动脉支架市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲生物可吸收冠状动脉支架市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东和非洲生物可吸收冠状动脉支架市场分析、洞察与预测2019-2032

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析 (2024)
  • 公司简介
    • 波士顿科学公司 (Boston Scientific Corporation)
    • 泰尔茂株式会社 (Terumo Corporation)
    • 瑞利思医疗器材有限公司 (Relisys Medical Devices Limited)
    • 微创医疗器材股份有限公司 (MicroPort Scientific Corporation)
    • 乐普医疗 (Lepu Medical)
    • 艾力达医疗 (Elixir Medical)
    • 中国医药集团有限公司 (SINOMED)
    • 瑞瓦医疗股份有限公司 (Reva Medical, LLC.)
    • ELLA-CS, s.r.o.
Product Code: FBI113733

Growth Factors of bioresorbable coronary stents Market

The global bioresorbable coronary stents market is witnessing steady expansion as the demand for advanced cardiovascular treatments increases worldwide. According to the latest market data, the global market size reached USD 340.5 million in 2024, is projected to grow to USD 356.0 million in 2025, and is expected to rise significantly to USD 520.4 million by 2032, reflecting a CAGR of 5.6% during the forecast period. North America dominated the global market in 2024, accounting for 38.59% of the total share owing to its strong healthcare infrastructure and high coronary intervention volume.

Bioresorbable coronary stents-also called scaffolds-are designed to gradually dissolve after opening blocked arteries, eliminating the long-term complications associated with permanent metallic implants. Made primarily from advanced polymers or biodegradable metals, these devices provide temporary mechanical support before safely degrading inside the body. Their ability to restore natural vasomotion and reduce the risk of late stent thrombosis has contributed significantly to rising adoption.

Market Drivers

The key driver of market growth is the increasing global prevalence of coronary artery disease (CAD). Lifestyle-related factors such as rising alcohol consumption, smoking, physical inactivity, and chronic stress are causing a surge in cardiac cases. For example, the CDC reported in October 2024 that nearly 1 in 20 U.S. adults aged 20+ suffered from CAD in 2023, highlighting the critical need for effective treatments. As aging populations expand worldwide, the number of patients requiring minimally invasive cardiology procedures continues to rise. Bioresorbable stents offer several clinical advantages, such as reduced long-term complications and restored vascular function, strengthening their demand in both developed and developing healthcare markets.

Market Restraints

Despite their benefits, bioresorbable coronary stents face strong competition from drug-eluting stents (DES) and metallic stents, which are well-established, cost-effective, and backed by extensive clinical data. While early results for bioresorbable devices are promising, more long-term evidence is needed to validate their safety and performance. Additionally, uncertainties regarding restenosis and long-term vessel healing remain concerns among clinicians, potentially slowing widespread adoption.

Market Opportunities

Significant growth opportunities are emerging in developing regions, driven by improving healthcare infrastructure and rising public awareness of cardiac diseases. Government-led initiatives, such as the Indian Ministry of Health's heart health campaign in September 2023, are helping educate patients about treatment options, including advanced stenting procedures. Hospitals worldwide are also expanding cardiology services. For instance, Canberra Hospital in Australia launched a new critical services building in August 2024 to expand cardiovascular intervention capabilities, supporting greater demand for bioresorbable stents.

Market Challenges

A major challenge in the market is the high cost of bioresorbable coronary stents, driven by advanced biomaterials and complex manufacturing processes. As of June 2025, BVS treatment in India ranged from USD 2,500-5,000, limiting affordability in low- and middle-income countries. Furthermore, companies must invest heavily in clinical trials and regulatory compliance, slowing product availability and market penetration.

Key Market Trends

Innovation remains central to market growth. Manufacturers are investing in new material technologies, enhanced drug-eluting capabilities, and improved stent designs. The launch of next-generation magnesium scaffolds, such as BIOTRONIK's Freesolve evaluated in the BIOMAG-II trial in May 2024, highlights significant progress. Hybrid stent designs and biosensor-integrated stents are emerging as future solutions, offering real-time monitoring and personalized treatment.

Regional Insights

North America

North America led the market in 2024 with USD 131.4 million in value. Strong CAD prevalence and increased adoption of minimally invasive procedures are driving regional demand.

Europe

Europe held the second-largest share, supported by rising obesity rates and strong product introductions. In England alone, 25.6% of adults were reported obese between 2021-2022.

Asia Pacific

Asia Pacific ranked third in 2024, driven by high smoking rates, stressful lifestyles, and increased stent placements. Stent treatment cases increased from 13.8% in 2019 to 19.4% in 2021.

Latin America & Middle East & Africa

These regions continue to grow due to rising hypertension, diabetes, and lifestyle-related risks.

Conclusion

With the market increasing from USD 340.5 million in 2024 to USD 356.0 million in 2025, and projected to reach USD 520.4 million by 2032, the bioresorbable coronary stents market is positioned for sustained growth. Advances in biomaterials, rising cardiovascular cases, and global expansion of cardiology services will continue to shape the industry's trajectory.

Segmentation By Application

  • Acute Coronary Syndrome (ACS)
  • Chronic Coronary Syndrome (CCS)

By End-user

  • Hospitals & ASCs
  • Specialty Clinics
  • Others

By Geography

  • North America (By Material, Application, End-user, and Country/Sub-region)
    • U.S.
    • Canada
  • Europe (By Material, Application, End-user, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Material, Application, End-user, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Material, Application, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Material, Application, End-user, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Incidence of Key Diseases, By Key Countries/Regions, 2023/2024
  • 4.2. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)
  • 4.3. Technological Advancements in the Bioresorbable Coronary Stents
  • 4.4. New Product Launches
  • 4.5. Reimbursement Scenario for Key Procedures

5. Global Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Material
    • 5.1.1. Metal
    • 5.1.2. Polymer
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Acute Coronary Syndrome (ACS)
    • 5.2.2. Chronic Coronary Syndrome (CCS)
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Material
    • 6.1.1. Metal
    • 6.1.2. Polymer
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Acute Coronary Syndrome (ACS)
    • 6.2.2. Chronic Coronary Syndrome (CCS)
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Material
    • 7.1.1. Metal
    • 7.1.2. Polymer
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Acute Coronary Syndrome (ACS)
    • 7.2.2. Chronic Coronary Syndrome (CCS)
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Material
    • 8.1.1. Metal
    • 8.1.2. Polymer
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Acute Coronary Syndrome (ACS)
    • 8.2.2. Chronic Coronary Syndrome (CCS)
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Material
    • 9.1.1. Metal
    • 9.1.2. Polymer
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Acute Coronary Syndrome (ACS)
    • 9.2.2. Chronic Coronary Syndrome (CCS)
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Material
    • 10.1.1. Metal
    • 10.1.2. Polymer
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Acute Coronary Syndrome (ACS)
    • 10.2.2. Chronic Coronary Syndrome (CCS)
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Boston Scientific Corporation
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Terumo Corporation
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Relisys Medical Devices Limited
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. MicroPort Scientific Corporation
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Lepu Medical
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Elixir Medical
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. SINOMED
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Reva Medical, LLC.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. ELLA - CS, s.r.o
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
  • Table 2: Global Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
  • Table 3: Global Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
  • Table 4: Global Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Region, 2019-2032
  • Table 5: North America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
  • Table 6: North America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
  • Table 7: North America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
  • Table 8: North America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country, 2019-2032
  • Table 9: Europe Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
  • Table 10: Europe Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
  • Table 11: Europe Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
  • Table 12: Europe Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032
  • Table 13: Asia Pacific Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
  • Table 14: Asia Pacific Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
  • Table 15: Asia Pacific Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
  • Table 16: Asia Pacific Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032
  • Table 17: Latin America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
  • Table 18: Latin America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
  • Table 19: Latin America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
  • Table 20: Latin America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032
  • Table 21: Middle East & Africa Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
  • Table 22: Middle East & Africa Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
  • Table 23: Middle East & Africa Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
  • Table 24: Middle East & Africa Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Bioresorbable Coronary Stents Market Revenue Breakdown (USD million, %) by Region, 2024 & 2032
  • Figure 2: Global Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024 & 2032
  • Figure 3: Global Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024 & 2032
  • Figure 4: Global Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024 & 2032
  • Figure 5: Global Bioresorbable Coronary Stents Market Value (USD million), by Region, 2024 & 2032
  • Figure 6: North America Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
  • Figure 7: North America Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
  • Figure 8: North America Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
  • Figure 9: North America Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
  • Figure 10: North America Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
  • Figure 11: North America Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
  • Figure 12: North America Bioresorbable Coronary Stents Market Value (USD million), By Country, 2024 & 2032
  • Figure 13: North America Bioresorbable Coronary Stents Market Value Share (%), By Country, 2024
  • Figure 14: Europe Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
  • Figure 15: Europe Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
  • Figure 16: Europe Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
  • Figure 17: Europe Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
  • Figure 18: Europe Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
  • Figure 19: Europe Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
  • Figure 20: Europe Bioresorbable Coronary Stents Market Value (USD million), By Country/Sub-region, 2024 & 2032
  • Figure 21: Europe Bioresorbable Coronary Stents Market Value Share (%), By Country/Sub-region, 2024
  • Figure 22: Asia Pacific Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
  • Figure 23: Asia Pacific Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
  • Figure 24: Asia Pacific Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
  • Figure 25: Asia Pacific Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
  • Figure 26: Asia Pacific Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
  • Figure 27: Asia Pacific Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
  • Figure 28: Asia Pacific Bioresorbable Coronary Stents Market Value (USD million), By Country/ Sub-region, 2024 & 2032
  • Figure 29: Asia Pacific Bioresorbable Coronary Stents Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 30: Latin America Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
  • Figure 31: Latin America Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
  • Figure 32: Latin America Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
  • Figure 33: Latin America Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
  • Figure 34: Latin America Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
  • Figure 35: Latin America Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
  • Figure 36: Latin America Bioresorbable Coronary Stents Market Value (USD million), By Country/ Sub-region, 2024 & 2032
  • Figure 37: Latin America Bioresorbable Coronary Stents Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 38: Middle East & Africa Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
  • Figure 39: Middle East & Africa Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
  • Figure 40: Middle East & Africa Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
  • Figure 41: Middle East & Africa Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
  • Figure 42: Middle East & Africa Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
  • Figure 43: Middle East & Africa Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
  • Figure 44: Middle East & Africa Bioresorbable Coronary Stents Market Value (USD million), By Country/ Sub-region, 2024 & 2032
  • Figure 45: Middle East & Africa Bioresorbable Coronary Stents Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 46: Global Bioresorbable Coronary Stents Market Share (%), By Company, 2024